TY - JOUR AU - Andre De Souza AU - Muhammad Saif PY - 2014/07/28 Y2 - 2024/03/28 TI - Thromboembolism and Pancreatic Cancer JF - JOP. Journal of the Pancreas JA - JOP VL - 15 IS - 4 SE - Highlights from the “50th ASCO Annual Meeting 2014”. Chicago, IL, USA. May 30 - June 3, 2014 DO - 10.6092/1590-8577/2574 UR - http://www.serena.unina.it/index.php/jop/article/view/2574 AB - Venous thromboembolism (VTE) is a frequent event in the clinical course of patients with exocrine pancreatic cancer; studies have been designed to evaluate the role of prophylactic anticoagulation in this ominous disease. Searching for the molecular basis of thrombosis in cancer, Bozkurt et al. present in the Abstract #e22049 the result of their investigation on the frequency of inherited and carcinogenesis-acquired proteins in oncologic patients with and without venous thromboembolism. From the bedside, Muñoz Martin et al. present in the Abstract #e15187 their work on the incidence of venous thromboembolism in patients with exocrine pancreatic cancer and the role of the established Khorana score in predicting symptomatic and incidental venous thromboembolism. At last, Cella et al. in the Abstract #e20625 expand the predictor landscape from the Khorana score to other risk factors for venous thromboembolism, refining the selection of oncologic patients who can benefit from prophylactic anticoagulation.Image: Thrombus ER -